Johnson & Johnson (JNJ) Free Cash Flow (2009 - 2025)
Johnson & Johnson (JNJ) posted Free Cash Flow of $6.36 billion for Q3 2026, down 20.6% from $8.01 billion a year earlier and down 12.8% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Free Cash Flow (2009 - 2025) Analysis & Trends
For the trailing twelve months through Sep 27, 2026, Free Cash Flow at Johnson & Johnson was $20.59 billion, up 5.1% year-over-year; for FY2025, it was $19.7 billion, down 0.7% from FY2024.
- Annual Free Cash Flow shows a four-year compound annual growth rate of -0.6% (FY2021 to FY2025).
- In prior years, Johnson & Johnson's Free Cash Flow was $19.84 billion in FY2024 (+8.7%), $18.25 billion in FY2023 (+6.2%), $17.19 billion in FY2022 and $20.19 billion in FY2021.
- Quarterly Free Cash Flow has run from a low of $1.47 billion in Q1 2026 to a high of $8.01 billion in Q3 2025 over five years.
- On a year-over-year basis, Free Cash Flow increased in four of the last eight quarters, with growth averaging 7.8%.
- The strongest year-over-year quarter for Free Cash Flow in the past five years was Q4 2023, with growth of 259.7%; the weakest was Q1 2026, with a decline of 56.6%.
- According to Business Quant data, Free Cash Flow for the three prior quarters was $7.3 billion (Q2 2026), $1.47 billion (Q1 2026) and $5.47 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.97 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.70 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.36 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 17.60 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 11.77 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 8.10 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 9.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 9.08 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 3.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 28, 2025 | 19.70 Bn |
| Dec 29, 2024 | 19.84 Bn |
| Dec 31, 2023 | 18.25 Bn |
| Dec 31, 2022 | 25.20 Bn |
| Dec 31, 2021 | 27.06 Bn |
| Dec 31, 2020 | 26.88 Bn |
| Dec 29, 2019 | 19.92 Bn |
| Dec 30, 2018 | 18.53 Bn |
| Dec 31, 2017 | 17.78 Bn |
| Dec 31, 2016 | 21.99 Bn |
| Dec 31, 2015 | 23.03 Bn |
| Dec 28, 2014 | 15.00 Bn |
| Dec 29, 2013 | 13.82 Bn |
| Dec 30, 2012 | 12.46 Bn |
| Dec 31, 2011 | 17.19 Bn |
| Dec 31, 2010 | 18.77 Bn |
| Dec 31, 2009 | 18.94 Bn |
API Access
Johnson & Johnson Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow-annual", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();